Syneron Q3 profit misses estimates

* Q3 EPS (Reuters) - Aesthetic laser device maker Syneron Medical Ltd (ELOS.O) reported a lower quarterly profit that also missed market expectations as doctors postponed new capital equipment purchases due to economic slowdown and tighter credit terms.

The Israel-based company said it was taking significant steps, including rationalizing its North American and European operations, to optimize its cost structure.

Net income for the third quarter was $2.2 million, or 8 cents a share, compared with $8.0 million, or 28 cents a share in the year-ago quarter. Revenue fell 14 percent to $28.5 million.

Shares of the company closed at $9.27 Monday on Nasdaq.

For the press release, please click [nMKW50928a] . For the alerts, please click [nWNAB1565]

(Reporting by Esha Dey in Bangalore; Editing by Jarshad Kakkrakandy)